Keywords: Ebselen, Selenite, Selenomethionine, Selenoprotein, Sodium Selenite, Aberrant Crypt Focus, Bladder Cancer, Cancer Incidence, Cancer Mortality, Cancer Prevention, Carcinogenesis, Chemoprophylaxis, Controlled Clinical Trial (topic), Dna Damage, Dna Repair, Drug Efficacy, Drug Mechanism, Human, Lung Cancer, Nonhuman, Priority Journal, Prostate Cancer, Review, Animals, Chemoprevention, Dietary Supplements, Dna Adducts, Glutathione Peroxidase, Models, Neoplasms, Thioredoxin-Disulfide Reductase, Drug Effects, Metabolism, Administration, Dosage, Dna Adducts Drug Effects
, Dna Repair Drug Effects
, Glutathione Peroxidase Metabolism
, Neoplasms Prevention, Selenium Administration, Selenoproteins Metabolism
, Thioredoxin-Disulfide Reductase Metabolism,
Affiliations: *** IBB - CNR ***
Department of Pathology, University of Illinois at Chicago, Chicago, IL, United States
Université Joseph Fourier, Grenoble 1, CEA, INAC, SCIB, Laboratoire Lésions des Acides Nucléiques, 17 rue des Martyrs, F-38054 Grenoble Cedex 9, France
Istituto di Biostrutture e Bioimmagini, CNR, Via De Amicis 95 Naples, Italy
References: Not available.
Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention?